Abingworth LLP Nu Cana PLC Transaction History
Abingworth LLP
- $301 Million
- Q4 2022
A detailed history of Abingworth LLP transactions in Nu Cana PLC stock. As of the latest transaction made, Abingworth LLP holds 3,333,333 shares of NCNA stock, worth $9.33 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
3,333,333
Previous 3,333,333
-0.0%
Holding current value
$9.33 Million
Previous $3.4 Million
35.32%
% of portfolio
0.73%
Previous 1.16%
Shares
1 transactions
Others Institutions Holding NCNA
# of Institutions
23Shares Held
11.3MCall Options Held
0Put Options Held
0-
Sofinnova Investments, Inc. Menlo Park, CA3.4MShares$9.52 Million0.05% of portfolio
-
Carlyle Group Inc. Washington, DC3.33MShares$9.33 Million0.06% of portfolio
-
Acadian Asset Management LLC Boston, MA591KShares$1.65 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny421KShares$1.18 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il89.3KShares$250,1630.0% of portfolio
About NuCana plc
- Ticker NCNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,196,000
- Market Cap $146M
- Description
- NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...